Gainers
- AIM ImmunoTech Inc AIM shares rose 87.4% to $3.1021 after the company announced that the Department of Defense has granted a four-year, $6.42 million "Breakthrough Award" to Roswell Park Comprehensive Cancer Center for a clinical study of the company's drug Ampligen, in patients with brain-metastatic breast cancer.
- Eros International Plc EROS rose 22.1% to $3.10 after the company announced it would collaborate with Microsoft to develop the next generation online video platform.
- Euro Tech Holdings Company Limited CLWT shares climbed 19.4% to $5.04 after the company declared issuance of bonus shares.
- Westwater Resources, Inc. WWR shares gained 15.5% to $3.58 after the company announced agreement to purchase natural flake graphite for Coosa Project.
- Lineage Cell Therapeutics Inc LCTX gained 14.5% to $1.1450 after the company recieved the CE Mark approval for Renevia. NOTE: The CE Mark provides Lineage the authority to market and distribute Renevia throughout the European Union and in other countries that recognize the CE Mark.
- Edesa Biotech, Inc. EDSA rose 13.8% to $7.00.
- electroCore, Inc. ECOR gained 12.4% to $5.34.
- China Biologic Products Holdings Inc CBPO gained 10.7% to $114.22 after the company announced it received an offer to take the company private for $120 per share.
- Commercial Vehicle Group, Inc. CVGI climbed 8.2% to $7.88.
- Abeona Therapeutics Inc ABEO climbed 7.7% to $3.45.
- NovaBay Pharmaceuticals, Inc. NBY gained 7.6% to $0.74 on continued momentum after the company announced it received approval for its Avenov by the Australian Therapeutic Goods Administration.
- Enphase Energy Inc ENPH shares rose 7% to $26.94.
- Farmer Bros Co FARM gained 6.5% to $14.86.
- Herman Miller, Inc. MLHR rose 4.5% to $46.46 after the company reported better-than-expected Q1 EPS and sales results. The company also issued FY20 sales guidance above analyst estimates.
Check out these big penny stock gainers and losers
Losers
- McDermott International, Inc. MDR shares tumbled 27.6% to $1.56 on continued momentum after the company announced it has hired advisors to 'evaluate opportunities' for the company in order to improve capital structure and the balance sheet.
- VBI Vaccines Inc VBIV shares dipped 25.6% to $0.50 after the company reported a common stock offering with no size disclosed.
- Zynerba Pharmaceuticals Inc ZYNE shares dropped 16.7% to $7.36 on continued momentum after Zygel safety data showed 96% of patients experienced a treatment emergent adverse event.
- SPI Energy Co., Ltd. SPI fell 12.7% to $3.28 after surging 74.07% on Wednesday.
- United States Steel Corporation X fell 12.3% to $10.92 after the company issued Q3 EPS guidance below analyst estimates.
- Lexicon Pharmaceuticals, Inc. LXRX dipped 11.3% to $3.37 as traders potentially took profits after the stock increased roughly 50% since last week.
- Foundation Building Materials Inc FBM dropped 11% to $16.86 after reporting secondary offering of common stock by selling stockholder.
- Pintec Technology Holdings Ltd PT dropped 10.6% to $2.27.
- Seadrill Ltd SDRL shares fell 10.3% to $2.61.
- EZCORP Inc EZPW dropped 10.1% to $7.42.
- Viveve Medical, Inc. VIVE fell 9% to $7.10. Viveve submitted Investigational Testing Application to conduct short-term feasibility study in stress urinary incontinence.
- Provention Bio, Inc. PRVB fell 8.8% to $8.81. Provention Bio priced its 5 million share public offering of common stock at $8 per share.
- Gogo Inc GOGO shares dropped 7.7% to $6.57.
- Sintx Technologies, Inc. SINT shares fell 6.6% to $2.54 after rising 8.80% on Wednesday.
- Antero Midstream Corp AM shares fell 6.5% to $7.20. This could potentially be profit taking from investors after the stock increased approximately 9% on Monday amid heightened tensions following an attack on a Saudi Arabian oil field. The stock price is currently back to what it was prior to the attack.
- Overstock.com, Inc. OSTK shares fell 5.3% to $15.34 after the company's CEO Patrick Byrne sold his stake in the company.
- Ares Management Corporation ARES shares fell 5% to $29.28. Ares Management reported pricing of 7 million share offering of Class A common stock at $29.90 per share.
- Grupo Supervielle S.A. SUPV dropped 4.1% to $2.85 after Bank of America downgraded the stock from Neutral to Underperform and lowered the price target from $9 to $2 per share.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in